Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy - Press Release

SHANGHAI, Aug. 6, 2022 /PRNewswire/ -- Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene

Related Keywords

China ,Shanghai ,United States ,Hong Kong ,America ,Michael Xue ,Bob Zhang ,Epigenic Therapeutic Technology Platform ,Epigenic Therapeutics Co Ltd ,Trinity Innovation Fund ,Series Angel ,Morningside Venture Capital ,Kingray Capital ,Fountainbridge Capital ,Epigenic Therapeutics ,Managing Director ,Morningside Venture ,Epigenic Therapeutic ,Chan Family ,North America ,Innovation Fund ,Yeah Capital ,Tigeryeah Capital ,